Skip to content

TO COMPARE 0.5% LEVOBUPIVACAINE HEAVY AND 0.75% ROPIVACAINE HEAVY FOR SPINAL ANAESTHESIA IN LOWER LIMB ORTHOPAEDIC SURGERIES

A COMPARATIVE STUDY OF 0.5% HYPERBARIC LEVOBUPIVACAINE AND 0.75% HYPERBARIC ROPIVACAINE FOR SPINAL ANAESTHESIA IN LOWER LIMB ORTHOPAEDIC SURGERIES

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/02/050087
Enrollment
60
Registered
2023-02-26
Start date
Unknown
Completion date
Unknown
Last updated
2023-03-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M958- Other specified acquired deformities of musculoskeletal system

Interventions

Intervention1: Sub Arachnoid Block: On the day of surgery Intravenous (IV) access will be secured. In the operation theater standard monitoring devices will be attached, including noninvasive arterial

Sponsors

JSSAHER
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: ASA physical status I â?? II patients of either sex between age 18- 60 years. Patients undergoing lower limb orthopaedic surgeries.

Exclusion criteria

Exclusion criteria: 1. Patient refusal for the procedure. 2. Spinal anomalies. 3. Any contraindications to spinal anaesthesia such as local infection at site of injection, allergy to the drugs, raised intracranial pressure, deranged coagulation profile. 4. ASA physical status III and above.

Design outcomes

Primary

MeasureTime frame
1.To compare the efficacy of sensory and motor blockade of 0.5% Hyperbaric Levobupivacaine and 0.75% Hyperbaric Ropivacaine in spinal anaesthesia for lower limb orthopaedic surgeries.Timepoint: Assessments of sensory and motor block will be continued at 30 min intervals thereafter until complete motor and sensory blocks regression.

Secondary

MeasureTime frame
1.Intraoperative hemodynamic changes 2.Time for first post operative rescue analgesia requirement. 3.Incidence of adverse events such as nausea and vomiting in the postoperative period. Timepoint: Assessment will be continued until complete motor and sensory block regression.

Countries

India

Contacts

Public ContactDr BP Manjula

JSS Academy of Higher Education

bpmanjula5@gmail.com9845501226

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026